2nd Quarter - Termination Amendment
PAMELA BRADLEY for ADAPTIVE BIOTECHNOLOGIES CORP
Firm
Income
$10,000
Expenses
—
Terminated
Apr 8, 2022
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
2023 appropriations requests for NIH for T cell research in COVID19 and other disease areas; HR4128 and S2209 The VALID Act. Provisions related to first of a kind assays
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA BRADLEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.